Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T cell response (British Journal of Haematology, 2022)

(untitled) - Ramasamy, K; Sadler, R; Jeans, S; Weeden, P; Varghese, S; Turner, A; Larham, J; Gray, N; Carty, O; Barrett, J; Bowcock, S; Oppermann, U; et al.